2019-nCoV NP Antibody (6G9)

ELK Biotechnology
Product Code: ELK-EPT257
Product Group: Primary Antibodies
CodeSizePrice
ELK-EPT257-1mg1mg£1,216.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Virus
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Target Species: SARS-CoV-2
Application: Neutralisation
Shipping:
The product is shipped on dry ice pack.
Storage:
24 months from manufacturing at <-20 °C; 1 month, 2 to 8 °C under sterile conditions.

Further Information

Background:
Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
Biological Activity:
Immobilized 2019-nCoV NP Antibody(6G9)-Fc(Cat#DA027) at 5ug/ml(100 ul/well) can bind 2019-nCoV Nucleocapsid Protein-His(Cat#DRA31). The ED50 of 2019-nCoV Nucleocapsid Protein-His(Cat#DRA31) is 0.1-0.7 ng/ml.